Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstroms Macroglobulinemia”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07766421
What this trial is testing

Evaluation of Iopofosine I 131 vs. R-CD in WM Patients

Who this might be right for
Waldenstrom MacroglobulinaemiaWaldenstrom MacroglobulinemiaWaldenstrom's Macroglobulinaemia Refractory+2 more
Cellectar Biosciences, Inc. 219
Testing effectiveness (Phase 2)Study completedNCT00832234
What this trial is testing

Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia

Who this might be right for
Waldenstroms Macroglobulinemia
European Myeloma Network B.V. 59
Testing effectiveness (Phase 2)Study completedNCT00250926
What this trial is testing

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Looking for participantsNCT04728893
What this trial is testing

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Who this might be right for
Hematologic MalignanciesWaldenstroms MacroglobulinaemiaNon-Hodgkins Lymphoma+1 more
Merck Sharp & Dohme LLC 490
Early research (Phase 1)Looking for participantsNCT07691606
What this trial is testing

ARC-02 in B-cell NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Taiho Oncology, Inc. 140
Not applicableWithdrawnNCT02298816
What this trial is testing

B-Cell Hematologic Malignancy Vaccination Registry

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia+4 more
Wake Forest University Health Sciences